In order to mediate cellular response to lipopolysaccharide (LPS), Toll-like receptor (TLR) 4 must interact with MD-2, a secreted protein. In this study, a biochemical assay was developed to demonstrate that recombinant MD-2 can interact with the extracellular portion of TLR4 in solution. The ability of MD-2 to multimerize was confirmed, and MD-1 was also shown to possess this ability. Through site-directed mutagenesis, more than two intermolecular disulfide bonds were found to stabilize the MD-2 multimer. MD-2's abilities to confer LPS responsiveness and to bind TLR4 were strongly associated functions. Remarkably, although the majority of recombinant MD-2 exists in multimeric form, monomeric MD-2 was found to preferentially bind TLR4 and to confer LPS responsiveness more efficiently than MD-2 multimers.
In order to mediate cellular response to lipopolysaccharide (LPS), Toll-like receptor (TLR) 4 must interact with MD-2, a secreted protein. In this study, a biochemical assay was developed to demonstrate that recombinant MD-2 can interact with the extracellular portion of TLR4 in solution. The ability of MD-2 to multimerize was confirmed, and MD-1 was also shown to possess this ability. Through site-directed mutagenesis, more than two intermolecular disulfide bonds were found to stabilize the MD-2 multimer. MD-2's abilities to confer LPS responsiveness and to bind TLR4 were strongly associated functions. Remarkably, although the majority of recombinant MD-2 exists in multimeric form, monomeric MD-2 was found to preferentially bind TLR4 and to confer LPS responsiveness more efficiently than MD-2 multimers.
Innate immunity relies on the ability of cells of the immune system to recognize molecular motifs that distinguish classes of microorganisms through germ line-encoded pattern recognition receptors (1, 2) . The lipopolysaccharide (LPS) 1 found in the outer membrane of Gram-negative bacteria is among the best characterized pathogen-associated molecular patterns. An extremely low concentration of LPS can be sensed by immunocompetent cells, such as macrophages and dendritic cells, leading to the activation of intracellular signaling pathways and the production of cytokines and other molecules that are required to fight the invading microorganism and activate the adaptive immune system.
At least four cellular proteins are known to participate in LPS recognition and cellular activation (3) (4) (5) . CD14 is a glycosylphosphatidylinositol-linked cell surface protein that serves as the major LPS receptor but is itself devoid of signaling capacity. CD14 is aided in LPS recognition by LPS-binding protein, a serum protein that acts as a lipid transferase. The signaling subunit of the LPS receptor is TLR4, a member of the TLR family. TLR4 is a type I transmembrane protein that contains in the cytoplasmic region a Toll-interleukin-1 receptor domain that links the receptor to the signaling machinery shared by interleukin-1 and interleukin-18. Lastly, MD-2, a secreted protein that is retained on the cell surface through interaction with TLR4, is also indispensable for TLR4 signaling in response to LPS. MD-2 shares sequence homology with MD-1, a protein that binds RP105, a TLR family member preferentially expressed on B cells (6) . Although it has been shown that CD14, TLR4, and MD-2 all lie in close proximity to the LPS molecule (7), the relative contribution of each receptor subunit to the recognition event and signal transduction is not entirely understood. The role of MD-2 is particularly puzzling. Both biochemical (8) and genetic (9) evidence demonstrated the absolute requirement of this protein for TLR4 function. However, MD-2 lacks structural features that would suggest its direct involvement in the transduction of the signal. Rather, MD-2 appears to be involved in agonist recognition; the ability of Taxol to stimulate mouse but not human TLR4 is dependent on the N-terminal region of mouse MD-2 (10); moreover, MD-2 directly binds LPS with an affinity similar to that of CD14 (11) . The role of MD-2 is rendered even more confusing by the fact that most TLRs, with the exception of TLR4 and RP105, do not seem to rely on MD-2 or MD-2-like proteins for their function. Recently, MD-2 was reported to form disulfide-linked multimers (12) , adding a further level of complexity.
In this study, the interaction between MD-2 and soluble TLR4 and their relationship to LPS responsiveness have been examined in some detail. Remarkably, although the majority of MD-2 exists in multimeric form, monomeric MD-2 was shown to preferentially bind TLR4 and to confer LPS responsiveness more efficiently than MD-2 multimers.
EXPERIMENTAL PROCEDURES
Cells and Transfection-HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. HeLa cells (7 ϫ 10 6 ) were transfected by electroporation (250 V, 950 microfarads) with 30 g of plasmid mixture in Dulbecco PBS/1.25% Me 2 SO. Cells were replated in a 10-cm plate in fetal calf serum-containing medium to allow recovery and cell adhesion. After 12 h, plates were rinsed in PBS, and 6 ml of serum-free medium 293 SFM (Invitrogen) were added. Media were collected 24 -48 h later. The HeLa-TLR4 cell line was described previously (13) .
Luciferase Assay-HeLa-TLR2, HeLa-TLR4, or HeLa-TLR4/MD2 cells were transiently transfected in 6-well plates using Superfect reagent (Qiagen, Valencia, CA) with 0.5 g of ELAM-luciferase and 1 g of pcDNA-CD14 (kindly provided by Dr. D. Golenbock, University of Massachusetts) and 0.1 g of CMV-␤-galactosidase. Luciferase assay was performed using Promega (Madison, WI) reagents according to the manufacturer's recommendations. Efficiency of transfection was normalized by measuring ␤-galactosidase in cell lysates.
Expression Vectors-Expression vectors for FLAG-TLR4, Myc-TLR4, and FLAG-TLR2 were described previously (13) . Soluble forms of TLR4 and TLR2 were expressed using these vectors after the following modifications. FLAG-sTLR4-His and Myc-sTLR4-His were generated by adding a 6-histidine tag after amino acid 634 of TLR4. The EcoRVBamHI fragment of pCMV-FLAG-TLR4 or pCMV-Myc-TLR4 was re-* This work was supported in part by National Institutes of Health Grants 5R35-CA47554 and N01-AI45198 (to J. L. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ placed with a EcoRV-BamHI fragment generated by PCR using PfuTurbo DNA polymerase (Stratagene) with the following primers: sT4RV, CAGGAAAACTTCCTTCCAGATATCTTC; and sT4His, GCGC-GGATCCTCAATGATGATGATGATGATGACCCTTATTCATCTGACA-GGTG. FLAG-sTLR4 lacking the His tag was generated by the same strategy using sT4RV primer and sT4H
Ϫ primer (GCGCGGATCCTCAC-CCGGGCTTATTCATCTGACAGGTGATATTC). FLAG-sTLR2 was generated by replacing the EcoRV-BamHI fragment of pCMV-FLAG-TLR2 with a EcoRV-BamHI fragment generated by PCR using the following primers: sT2Bam, ACTAACATTGATATCAGTAAGAATAG; and sT2His, GCGCGGATCCTCAATGATGATGATGATGATGACCTGTCCTGTG-ACATTCCGAC. MD-2-FLAG-His was expressed using the vector pEF-BOS-MD-2 kindly provided by Dr. K. Miyake (Saga Medical School). MD-2-FLAG lacking the His tag was generated by PCR using pEFBOS-MD-2 as template and the following primers: Bos5Ј, AGAGATCCCTC-GACCTCGAGC; and MD-2-His Ϫ , GATGCGGCCGCTCACTTGT-CATCGTCGTCCTTGTAGTCC. The PCR product was digested with XhoI-NotI and cloned into the XhoI-NotI sites of pEFBOS vector. MD-1 sequence was amplified from peripheral blood mononuclear cell total RNA by reverse transcription-PCR using the following primers: MD-1bam5, CGGATCCACCATGAAGGGTTTCACAGCCACTC; and MD-1xho3, GC-CTCGAGGGAGCACATGATAATAGTAGCATTG. The PCR product was cut with XhoI, blunted with Klenow enzyme, cut with BamHI, and cloned into a modified pcDNA3 vector (Invitrogen) containing a FLAG-His-Stopcodon or FLAG-Stop-codon cassette between NotI-XbaI sites that was cut with NotI, blunted with Klenow enzyme, and cut with BamHI. C terminus Myc-tagged MD-2 was generated by reverse transcription-PCR using the following primers: Hind3MD-2, GCTTGCGAAGCTTATCATGTTAC-CATTTCTGTTTTTTTC; and XhoMD-2, GCTTGCGCTCGAGATTT-GAATTAGGTTGGTGTAGG. The PCR product was cut with HindIIIXhoI and cloned into a modified pcDNA3 vector containing a Myc-Stopcodon cassette between XhoI-XbaI sites that was cut with HindIII-XhoI.
Site-directed Mutagenesis-All mutations (Cys to Ala) were introduced into pEFBOS-MD-2-FLAG-His using the QuikChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's recommendations and confirmed by sequencing. Primers sequences are available upon request.
Nickel Resin Chromatography and Immunoprecipitation-To capture histidine-tagged protein complex, filtered supernatants (typically 5 ml) were incubated overnight with ProBond nickel resin (Invitrogen) and washed in PBS, and the resin was resuspended in Laemmli sample buffer, boiled, and analyzed by SDS-PAGE and immunoblot. For immunoprecipitation, supernatants were incubated for 8 h with 3 g of anti-Myc mAb or anti-FLAG mAb that was previously immobilized and cross-linked to protein G-agarose with 30 mM dimethylpimelidate. The resin was washed in PBS, resuspended in Laemmli sample buffer, and analyzed by SDS-PAGE and immunoblot. For the experiments of Fig.  2B , FLAG-sTLR4 and MD-2-FLAG-His were purified from 200 ml of serum-free supernatants of transfected HeLa cells by anti-FLAG affinity-gel column and eluted with 3ϫ FLAG peptide (100 g/ml). Proteins were then concentrated using a Centricon concentrator (cut-off, 10) (Millipore, Bedford, MA), and an aliquot was analyzed by SDS-PAGE and silver staining. The concentration of the purified proteins was estimated by the Bradford method and by comparison with bovine serum albumin standards. Anti-FLAG M2 and biotinylated anti-FLAG M2 mAbs were purchased from Sigma. Anti-Myc mAb was purchased from Invitrogen.
Separation of MD-2 Monomer and Multimers-Culture supernatant containing MD-2-FLAG-His (300 ml) was passed over a nickel resin column (1 ml packed volume). The column was washed extensively with PBS. Elution of MD-2-FLAG-His was started by adding 1-ml aliquots of PBS containing imidazole. The first elution contained 60 mM imidazole. The second elution contained 125 mM imidazole. The last two contained 250 mM imidazole. An aliquot of each fraction (30 l) was analyzed by SDS-PAGE and immunoblot under nonreducing conditions. Fractions were concentrated using a Centricon concentrator (cut-off, 10) (Millipore), reconstituted in fetal calf serum-containing medium, and added to cells at a 1:1, 1:10, and 1:100 dilution.
RESULTS AND DISCUSSION

Soluble TLR4 and MD-2 Specifically Interact in Solution-
MD-2 interacts with TLR4 on the cell surface. However, whether or not the extracellular portion of TLR4 alone is sufficient for this interaction has never been demonstrated. A biochemical assay to characterize in more detail the interaction between MD-2 and TLR4 in solution was developed. Constructs were engineered to express the following proteins: the extracellular portions of human TLR4 (amino acids 24 -634, sTLR4) and TLR2 (amino acids 19 -588, sTLR2) were fused to the N-terminal FLAG tag, and in some constructs, a 6-histidine tag was also added at the C terminus to facilitate purification. MD-2 or MD-1 was fused to FLAG, Myc, or histidine tags. Fig.  1 shows a diagrammatic representation of the different constructs used for these studies.
To test whether MD-2 can interact with the extracellular domain of TLR4 alone in solution, HeLa cells were transiently co-transfected with vectors encoding FLAG-sTLR4-His and a construct encoding MD-2-FLAG. Cells were grown in serumfree medium for 48 h, FLAG-sTLR4-His was recovered from cell culture supernatants using nickel resin, and the presence of MD-2-FLAG in the resin pellet was checked by SDS-PAGE and immunoblot with anti-FLAG mAb. As shown in Fig. 2A , MD-2-FLAG was found to interact with FLAG-sTLR4-His. The interaction was specific because MD-2-FLAG failed to interact with a similarly engineered extracellular domain of TLR2 (FLAG-sTLR2-His) or of TLR3 (data not shown). FLAG-sTLR4-His did not interact with MD-1-FLAG. Reciprocally, FLAGsTLR4 without the histidine tag was able to co-purify on nickel resin with MD-2-FLAG-His (Fig. 2B) . This interaction occurred even in a cell-free system by mixing purified FLAG-sTLR4 and MD-2-FLAG-His (2 g of each) and was resistant to washes in 0.5 M NaCl/1% Nonidet P-40, indicating a strong interaction (Fig. 2B) . These experiments indicate that the extracellular domain of TLR4 alone is sufficient for the interaction with MD-2.
Oligomerization of MD-2-In the course of these experiments, MD-2 was found to be able to self-interact. As shown in Fig. 3A , MD-2-Myc co-purified on nickel resin with MD-2-FLAG-His but not with MD-1-FLAG-His. The interaction was resistant to high salt and detergent concentration but was disrupted by washes in dithiothreitol-containing buffer (data not shown), suggesting that the MD-2 complex was stabilized by disulfide bonds. To confirm this, MD-2-FLAG-His was captured on nickel resin and analyzed by SDS-PAGE in the presence or absence of a reducing agent and by immunoblotting with anti-FLAG mAb (Fig. 3B) . Whereas a single doublet with an apparent molecular mass of 25 kDa was detected in the presence of ␤-mercaptoethanol, several bands were detected under nonreducing conditions. The most prominent species had a molecular mass of 50 kDa, which is consistent with a MD-2 dimer. Additional bands with a molecular mass 75 and 100 kDa and higher were also detected, which likely represent MD-2 trimer, tetramer, and multimers. Thus, secreted MD-2 exists in monomeric and multimeric forms. The fact that the MD-2 multimers were resistant to boiling and were disrupted only by reducing conditions indicated that the MD-2 polymers might be covalently linked by disulfide bonds. The ability of MD-2 to oligomerize was also confirmed using a noncleavable cross- linking reagent (Fig. 3C) . The mobility of MD-2 shifted from 25 to 50 kDa upon treatment with Sulfo-DST. Similarly, the mobility of FLAG-sTLR4, co-purified with MD-2-FLAG-His, moved from 90 to Ͼ120 kDa, a complex that likely contains MD-2 and sTLR4. The absence in this experiment of bands corresponding to the multimers might reflect the low efficiency of the cross-linking reaction. MD-2 and MD-1 share high sequence homology. Five of the seven cysteine residues contained in MD-2 are conserved in MD-1. Therefore, it was not surprising to find that MD-1 is also able to form multimers (Fig. 3D) . These experiments demonstrated that MD-2 and MD-1 exist in both monomeric form and as disulfide-linked multimers of different sizes. While this manuscript was in preparation, Visintin et al. (12) reported a similar finding regarding the multimeric nature of MD-2.
In an attempt to identify which of the cysteine residues is responsible for MD-2 multimer formation, all seven cysteines contained in the MD-2-FLAG-His protein were mutagenized, one by one. All mutant proteins were secreted in the culture medium of transfected HeLa cells at comparable levels. When proteins were captured on nickel resin and analyzed by SDS-PAGE/immunoblotting under nonreducing conditions, they were all found to retain the multimeric form typical of the wild-type protein (data not shown). Thus, more than one disulfide bond must be involved in MD-2 oligomerization. Therefore, double mutant analysis was also performed. Of the 21 possible combinations, most double mutants yielded proteins that migrated under nonreducing conditions as multimers (data not shown). However, the double mutation C25A/C37A was not expressed, and C25A/C95A was expressed at a low level in multimeric form but was not secreted. The absolute lack of C25A/C37A expression makes it difficult to argue whether these cysteine residues are the ones responsible for the formation of multimers. If they were, one could argue that the inability to form multimer, as consequence of their mutation, renders MD-2 protein highly unstable and undetectable. However, because MD-2 can be expressed and secreted in monomeric form, this explanation does not seem plausible. Alternatively, MD-2 stability might be dependent on the formation of intramolecular bonds between these two cysteine residues, and their disruption would yield a protein so unstable as to be undetectable. Thus, it appears that more than two disulfide bonds stabilize MD-2 multimers. However, it is also conceivable that MD-2 multimers are not covalently linked by disulfide bonds, but rather their formation is dependent on the interaction between MD-2 monomer through structural features stabilized by intramolecular disulfide bonds and resistant to boiling in SDS, similarly to the dimerization of some G proteincoupled receptors (14, 15) . The study by Visintin et al. (12) also came to the conclusion that more than one disulfide bond is involved in MD-2 multimerization. Interestingly, that study reported the finding that the dimeric form of MD-2 was more resistant to mild reducing conditions than the multimer, leading the authors to propose that the multimer might be composed of several polymerized dimers. However, our data show that although the dimer appears to be the most abundant species, trimer, tetramer, and pentamer are also present, indicating that the polymerization of MD-2 might occur rather by sequential addition of monomers. Our studies, as well as those by Visintin et al. (12) , were performed using recombinant MD-2 protein produced by transfected cell lines. It is unknown at present whether endogenous MD-2 also exists in multimeric form. Antibodies to MD-2 are being raised and will help to clarify this point.
FIG. 2. MD-2 interacts with TLR4 ectodomain alone.
A, HeLa cells were transfected with the indicated expression vectors, and the protein complexes were purified from the culture supernatants by nickel resin chromatography, separated by SDS-PAGE, and detected by immunoblot with anti-FLAG mAb. The bottom panel shows anti-FLAG immunoprecipitation of an aliquot of the culture supernatants followed by immunoblot with biotinylated anti-FLAG mAb. B, purified FLAG-sTLR4 and MD-2-FLAG-His (ϳ2 g of each) were co-incubated for 1 h at 4°C and captured on nickel resin. The sample was split and washed with PBS or PBS containing 500 mM NaCl/1% Nonidet P-40. Proteins were separated by SDS-PAGE and detected by immunoblot with anti-FLAG mAb. Bottom panels show silver-stained gels of purified MD-2-FLAG-His and FLAGsTLR4 (indicated by arrows) used in this experiment and bovine serum albumin standard (protein amount is expressed in nanograms).
Interaction of MD-2 Cys
Mutants with sTLR4 -Next, the ability of mutant MD-2 proteins to interact with FLAG-sTLR4 was analyzed. As shown in Table I , MD-2 mutants C25A, C37A, C51A, C133A, and C148A retained the ability to interact with FLAG-sTLR4 and to confer LPS responsiveness to HeLa-TLR4, a stable cell line that expresses TLR4 and requires MD-2 for LPS responsiveness. In contrast, mutations C95A and C105A disrupted the interaction of MD-2-FLAG-His with FLAGsTLR4, as well as its ability to render HeLa-TLR4 responsive to LPS, as measured by nuclear factor B-dependent luciferase production. Recently, mutation of MD-2 at C95Y was found to be responsible for LPS unresponsiveness of a Chinese hamster ovary cell line (9). Interestingly, MD-2/C95Y was still able to bind TLR4. Considering the importance that cysteine residues have for determining the structure of extracellular proteins, it is surprising that only two of the seven mutations tested impaired MD-2's ability to confer LPS responsiveness and bind TLR4 and would support the contention that these are closely associated functions of MD-2. On the other hand, the finding that MD-2 is also capable of directly binding LPS (11) would suggest the existence of two functional domains of MD-2, one involved in LPS recognition and one used for TLR4 association. A more extensive mutational analysis will try to identify mutations that separate MD-2's ability to confer LPS responsiveness and bind TLR4.
Only the MD-2 Monomer Binds to sTLR4 -The finding that
FIG. 3. MD-2 and MD-1 form multimers.
A, interaction of MD-2-FLAG-His with MD-2-Myc. HeLa cells were transfected with the indicated expression vectors, and the protein complexes were purified from culture supernatants by nickel resin chromatography, separated by SDS-PAGE, and detected by immunoblot with anti-Myc mAb (top panel). A, middle panel, 1/20 of the samples were run separately and immunoblotted with anti-FLAG mAb to illustrate the presence of MD-2-FLAG-His and MD-1-FLAG-His. A, bottom panel, an aliquot of the culture supernatants was subjected to immunoprecipitation with anti-Myc mAb (cross-linked to protein G-agarose) followed by immunoblot with anti-Myc mAb to prove the presence of MD-2-Myc. B, formation of MD-2 oligomers in culture medium. MD-2-FLAG-His was purified from culture medium by nickel resin chromatography, separated by SDS-PAGE under reducing (R) or nonreducing (NR) conditions, and detected by immunoblot with anti-FLAG mAb. C, culture supernatants containing MD-2-FLAG-His or MD-2-FLAG-His and FLAG-sTLR4 were treated with Sulfo-DST at the indicated concentration for 1 h at room temperature, and the cross-linking agent was quenched by the addition of Tris, pH 7.5, at a final concentration of 20 mM. Proteins in supernatants were purified by nickel resin chromatography and separated by SDS-PAGE under reducing conditions followed by immunoblot with anti-FLAG mAb. D, formation of MD-1 oligomers in culture medium. MD-1-FLAG-His or MD-2-FLAG-His was purified from culture supernatants of transfected HeLa cells by nickel resin chromatography, separated by SDS-PAGE under reducing (R) or nonreducing (NR) conditions, and detected by immunoblot with anti-FLAG mAb. Two separate MD-1-FLAG-His samples were analyzed.
MD-2 exists in monomeric and multimeric form raised the question of which form of MD-2 binds TLR4. The possibility that a MD-2 multimer might bind more than one TLR4 molecule is very attractive because it would indicate that MD-2 can act as a scaffold that holds several TLR4 molecules in close proximity, possibly facilitating receptor dimerization during stimulation. However, sTLR4 was found to bind only monomeric MD-2, despite the fact that the majority of this protein in the medium was polymeric (Fig. 4) . In contrast to this result, it has been reported that TLR4 associates in the endoplasmic reticulum with different-sized oligomers of MD-2 (12). The reason for this discrepancy is unclear.
Monomeric MD-2 Confers LPS Responsiveness More Efficiently than MD-2 Multimers-Exogenously added MD-2 is able to render TLR4-expressing cell lines LPS-responsive (9, 11, 12) . Therefore, the ability of monomeric and multimeric MD-2 to render HeLa-TLR4 responsive to LPS was compared. Several methods, including gel filtration/high pressure liquid chromatography, were employed in the attempt to separate MD-2 monomer from multimers, but with poor results. However, fractions enriched in MD-2 monomer or multimers were obtained by exploiting the fact that monomeric MD-2 was found to elute from a nickel resin column loaded with MD-2-FLAG-His at a lower imidazole concentration than the multimers. As shown in Fig. 5A , the first fraction eluted with 60 mM imidazole was highly enriched in MD-2 monomer. The second fraction, eluted in 125 mM imidazole, contained monomer as well as multimers. The last two fractions, eluted with 250 mM imidazole, contained mainly MD-2 multimers and only traces of monomer. Fractions 1, 2, and 4 were added at different dilutions to the medium of HeLa-TLR4 cells transfected with ELAM-luciferase, and their ability to respond to LPS was measured by luciferase assay (Fig. 5B) . Fraction 1, enriched in monomeric MD-2, was found to confer LPS responsiveness more efficiently than fractions 2 and 4, which were enriched in MD-2 multimers, despite the fact that these fractions contained more MD-2 protein. At the highest dilution tested (1: 100), fraction 1 retained most of its activity, whereas fraction 2 activity was almost completely lost. Fraction 4, which contained only traces of MD-2 monomer, was even less efficient at rendering HeLa-TLR4 cells LPS-responsive and lost its activity at a 1:10 dilution. Thus, the ability of the different fractions to confer LPS responsiveness correlates with the amount of monomeric MD-2 rather than with the total amount of MD-2 protein, suggesting that only the MD-2 monomer is a functional partner of TLR4. C95A and C105A HeLa cells stably expressing FLAG-sTLR4 were transfected with the indicated MD-2-FLAG-His mutant constructs (left column), and the interaction between the two proteins (middle column) was tested as described in Fig. 2 . HeLa-TLR4 cells were transfected with the ELAMluciferase reporter vector, CMV-CD14, and the indicated MD-2-FLAGHis mutant constructs. Cells were stimulated for 6 h with LPS (0.1 ng/ml), and luciferase was measured in cell lysates.
MD-2-FLAG-His mutants
Binding to FLAG-sTLR4
a EGFP, enhanced green fluorescent protein; WT, wild-type.
FIG. 4. sTLR4 binds only monomeric MD-2.
HeLa cells were cotransfected with FLAG-sTLR4-His and MD-2-FLAG. Culture supernatant was split, and proteins were either captured on nickel resin or immunoprecipitated with anti-FLAG mAb (cross-linked to protein Gagarose). Proteins were separated by SDS-PAGE under nonreducing conditions and detected by immunoblot with anti-FLAG mAb. Two separate transfection experiments are shown.
FIG. 5.
Monomeric MD-2 confers LPS responsiveness more efficiently than MD-2 multimers. A, fractions enriched in MD-2 monomer or multimers (see "Experimental Procedures") were analyzed by SDS-PAGE under nonreducing conditions and detected by immunoblot with anti-FLAG mAb. B, MD-2 fractions were added at the indicated dilutions to HeLa-TLR4 cells transiently transfected with ELAM-luciferase and CMV-CD14. Cells were stimulated with LPS (1 ng/ml) for 6 h, and luciferase was measured in cell lysates.
tein, and macrophage scavenger receptor (16, 17) . In agreement with a LPS decoy function is the finding that the addition of purified MD-2 protein to cell types that express an endogenous level of TLR4 and MD-2, such as whole blood or U373 cells, inhibits rather than enhances responses to LPS (11) . The authors of that study proposed that the added MD-2 might compete with the endogenous TLR4/MD-2 complex for the available LPS. The fact that MD-2 is reported to be expressed in excess of TLR4 is also consistent with an additional role of MD-2 (12). MD-2 molecules that do not associate with TLR4 in the endoplasmic reticulum might end up forming multimers and being secreted in this form. The existence of MD-2 in monomeric and multimeric forms raises the further issue of how the conformation of the monomeric MD-2 molecule compares with that of the multimers. Clearly, the cysteine residues that participate in multimer formation must be differentially rearranged in the MD-2 monomer, suggesting that the structure of MD-2 in the monomer might differ considerably from the conformation of MD-2 molecules engaged in the multimers. This diversity in conformation might be the reason why multimers do not bind TLR4.
Although our results were obtained using recombinant proteins and therefore may not conclusively represent what happen on the cell surface with endogenous proteins, they support a model by which monomeric MD-2 associates with TLR4 to aid LPS signaling, whereas a definitive function for the secreted multimeric MD-2 remains to be established.
